©2024 Stanford Medicine
Use of New Supraglottic Airway Devices in Severely Obese Patients: A Feasibility Study
Not Recruiting
Trial ID: NCT01124825
Purpose
The purpose of this study is to determine whether two new airway devices used during anesthesia called iGEL™ and KING-LTS-DTM work well and are safe in obese patients. They both work well in thin patients, but have not been tested in obese patients.
Official Title
Use of New Supraglottic Airway Devices in Severely Obese Patients: A Feasibility Study
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
* Scheduled for elective surgery with an estimated duration of 30 to 120 minutes
* American Society of Anesthesiologists (ASA) status I-III
* Aged 18 to 65 years.
* Body mass index (BMI) ≥ 35 kg/m2
Exclusion Criteria:
* A history of difficult intubation;
* Immobilized cervical spine;
* Oxygen saturation less than 95% at room air;
* A history of uncontrolled gastroesophageal reflux or hiatus hernia;
* A history of ulcer surgery including vagotomy;
* Previous gastric bypass surgery;
* Diabetic gastroparesis;
* Patients with known coagulation disorders (e.g. hemophilias, von Willebrand disease, factor V leiden diseases) or on systemic anticoagulation drugs (e.g. continuous heparin infusion); Patients with abnormal coagulation tests will be also excluded. However, asymptomatic patients will not be tested on any coagulation disorders.
* Any pathologies of the mouth, pharynx or larynx, the access to the airway is restricted, or a difficult tracheal intubation is anticipated.
* Pregnant or breast-feeding (pregnancy status will be confirmed by a pregnancy test, as it is standard for all surgical procedures at the University hospital).
Intervention(s):
device: IGEL
device: King airway
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305